Abstract:Abstract Introduction: The loss of the antiproliferative responsiveness to TGF-β is often considered as a major step in tumor progression, thus allowing an increased and “uncontrolled” proliferation of many tumor cells. Smad4 is mutated or deleted in 55% of pancreatic cancers . However, what exact role Smad4 plays in TGF-β-mediated growth control of pancreatic ductal cancer cells remains unclear. Furthermore, status of Smad2/3 and Smad2 phosphorylation has never been analyzed in pancreatic cells. In this study, we seek to examine the essential role of Smad4 and of Smad2 phosphorylation in TGF-β-mediated growth arrest in pancreatic cancer cells. Methods: Expression of endogenous Smad2, Smad3, and Smad4 were examined by using Western blot in seven pancreatic ductal cell lines Panc1, Colo357, BxPC-3, CAPAN1, HS766T, Su86.86 and MiaPaCa2. Phosphorylation of Smad2 was immuno-detected by using anti-phospho-Smad2 antibodies after cells received TGF-β treatment. Cell growth was assessed by measuring DNA synthesis rate via 3H-thymindine incorporation. Transcription of cell cycle inhibitor p15 was analyzed by luciferase reporter assays. Results: Smad4 was only present in Panc1, Colo357 and MiaPaCa2 cells, while Smad2 and Smad3 were expressed in all cell lines tested. Upon TGF-β treatment, all cell lines except MiaPaCa2 showed a Smad2 phosphorylation, in agreement with reported loss of type II TGF-β receptor in MiaPaCa2 cells. This supports the notion that phosphorylation of Smad2 is an event prior to its interaction with Smad4. Importantly, we observed that TGF-β induced inhibition of DNA synthesis by 50–70% in Panc1 and Colo357 cells, by 15% in BxPc3 cells, and it had no inhibition in other cell lines. Accordingly, transcription of the p15 gene was induced by TGF-β in Colo357 cells. These results suggest that TGF-β-induced growth arrest was closely correlated with Smad2 phosphorylation and the presence of Smad4. Conclusion: Our data suggest that loss of Smad2 phosphorylation and functional Smad4 lead to abrogation of TGF-β-mediated tumor suppressing functions and thus contribute to pancreatic tumorigenesis.

Transforming Growth Factor Beta Suppresses Beta-Catenin/Wnt Signaling and Stimulates an Adhesion Response in Human Colon Carcinoma Cells in A Smad4/Dpc4 Independent Manner

Tgf Beta Signaling In Pancreatic Ductal Adenocarcinoma

Expression of TGF-β1, TβRII and Smad4 in Colorectal Carcinoma

[Influence of Smad4-independent Pathway of Transforming Growth Factor Beta1 on the Biological Activity of Pancreatic Cancer Cells].

TGF-β inhibits growth of pancreatic ductal epithelial cells through receptor-mediated activation of Smad proteins

Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1

TACE-Mediated Ectodomain Shedding of the Type I TGF-b Receptor Downregulates TGF-b Signaling

Effect of Transforming Growth Factor-β1 on the Proliferation and Invasion of Human Colon Carcinoma Cells

Tgf-Beta Promotes Colorectal Cancer Cell Growth In Vitro And In Vivo

Transforming Growth Factor Beta Signaling Pathway: A Promising Therapeutic Target For Cancer

TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling

Transforming Growth Factor Beta Promotes Inflammation and Tumorigenesis in Smad4‐Deficient Intestinal Epithelium in a YAP‐Dependent Manner

Abrogation of Transforming Growth Factor- Β Signaling in Pancreatic Cancer

Expression of TGF-β_1,TGF-β TypeII Receptor and Smad4 Protein in Colorectal Cancer Tissues

Transforming Growth Factor Β Signaling Pathway: A Promising Therapeutic Target for Cancer

Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma

The role of TGF-β/SMAD4 signaling in cancer

TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation

TGF-β Tumor Suppression Through a Lethal EMT

The Tumor Suppressor Smad4/Dpc4 and Transcriptional Adaptor Cbp/P300 Are Coactivators for Smad3 in Tgf-Beta-Induced Transcriptional Activation

Smad4 Signalling in T Cells is Required for Suppression of Gastrointestinal Cancer.